Rare diseases
Investigational molecules
Locations
FranceRandomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease
FrancePhase 2 Study of Nemolizumab for Skin Thickening in Adults with Systemic Sclerosis
FranceLong‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
FranceLong-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis
FranceStudy of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.
FranceA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
FranceA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
FranceA study testing XmAb942 compared to placebo in adults with moderate-to-severe active ulcerative colitis
FranceA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
FranceA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
FranceA study testing duvakitug for patients with moderately to severely active ulcerative colitis
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
